An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System
- Conditions
- Non Small Cell Lung Cancer4D CT
- Interventions
- Radiation: Stereotactic Radiosurgery
- Registration Number
- NCT02067858
- Lead Sponsor
- Steven Burton
- Brief Summary
The goals of this clinical research are to evaluate the outcomes and tumor response for early stage non-small lung cancer (NSCLC) patients undergoing Stereotactic Body Radiation Therapy (SBRT) using four dimensional (4D) Positron Emission Tomography (PET) and Computed Tomography (CT), Cone-Beam Computed Tomography (CBCT), Real-Time Position Management (RPM™) and body immobilization system (see figure 1). Specifically, the effect of image-guided SBRT treatment on clinical tumor response rate, local control and progression-free survival will be studied. This study will examine target volumes and relevant margins determined by an assessment using 4D PET and repeated 4D CT. These data will allow us to evaluate and determine the impact of the body immobilization system on the planning target volume (PTV) margins, patient's breathing pattern, target motion, and inter-treatment targets shifts.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 6
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Stereotactic Radiosurgery Stereotactic Radiosurgery 3 fractions x 20 Gy 4 fractions x 12 Gy Lesion dependent
- Primary Outcome Measures
Name Time Method Assess Clinical Response Rate and Local Control Following SBRT Treatment of Patients With Early Stage NSCLC 2 years The Number of Patients that completed SBRT
- Secondary Outcome Measures
Name Time Method Assess Progression-free Survival 2 years Number of patients with Progression Free Survival at 2 Years
Trial Locations
- Locations (1)
UPMC Shadyside Radiation Oncology Department
🇺🇸Pittsburgh, Pennsylvania, United States